Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Stock Hit Resistance and Fall, Transportation Sector Forms Topping Pattern

Recently, the Transportation Index and the S&P SPDR ETF setup topping patterns near the end of April 2020. In terms of technical triggers, these patterns need to see additional downside price confirmation before we can confirm the true potential for these setups. If they do ...

Are Financials Hinting At 2011/2016-Like Stock Market Rally?

TRYING TO MAKE A RELATIVE TURN The chart below shows the performance of financial stocks (XLF) relative to the S&P 500 (SPY). Since making a low in late 2011 (point A), the XLF:SPY ratio has been trading in the slightly upward-sloping blue trend channel. Anecdotally, it is...

Russell 2000 Gaps Present Real Targets

Recent Gaps in price action in the IWM (Russell 2000 ETF) presents a clear picture of future price targets and support/resistances. Gaps are one of the most common forms of Technical Analysis techniques. They represent “voids” where price activity has s...

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug ontheir research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account f...

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

ProMIS' preclinical treatment could possibly outshine Biogen's candidate. Finding an effective treatment for Alzheimer's disease has been elusive as many seemingly promising avenues of research did not prove out in clinical trials. Biogen Inc. (BIIB:NASDAQ) appeared...

Gold Pulled Back, But Coronavirus Did Not

While viruses are counted among the simplest forms of life, they have quite a bearing on its advanced forms. And the coronavirus epidemic is, unfortunately, alive and well. What are the implications for the gold market? Coronavirus Infects Europe The coronavirus epidemi...

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...

ADL Predicts Expected Range Of The NQ Before Breakout

Our advanced predictive modeling system is suggesting a defined range for the NQ over the next 30 to 60+ days before a bigger breakout move is expected. If you've been following our research, you already know we have been predicting the NQ to move in a sideways pennant for...

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

EpiPen manufacturer Mylan N.V. announced today that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. Mylan Inc. (MYL:NASDAQ) and Pfizer Inc. (PFE:NYSE) today anno...

Precious Metals Setting Up Another Momentum Base/Bottom

Just as we predicted, precious metals are setting up another extended momentum base/bottom that appears to be aligning with our prediction of an early October 2019 new upside price leg. Recent news of the US Fed decreasing the Fed Funds Rate by 25bp as well as strength in ...
1 2 3 4 5 6 7 8 9 10 ...